Carolyn Taylor, Founder and Executive Director at Global Focus on Cancer, shared on LinkedIn:
“What is the value of a scientific breakthrough if the people who need it cannot afford it?
Our Commentary in The Lancet Oncology challenges an uncomfortable reality: we celebrate extraordinary advances in cancer treatment while allowing profits to take precedence over people’s lives.
At a time when inequality is deepening and wealth and power increasingly shape whose interests are protected, why are we willing to accept the same injustice in cancer care?
The triumph of a scientific breakthrough is not fully realized when millions are excluded from its benefits. Ensuring equitable access is our collective responsibility.
Title: The unfulfilled promise of effective cancer medicines priced beyond reach
Authors: Christopher M Booth, Carolyn Taylor, Christopher G C A Jackson, Michelle Tregear, Manju Sengar, Brooke E Wilson, Ian F Tannock, Bishal Gyawali, Scott R Berry, Haydeé Verduzco-Aguirre, Craig Leroux, Richard Sullivan
Other articles featuring Carolyn Taylor on OncoDaily.